Skip to main content
Log in

Ketanserin causes surmountable antagonism of 5-hydroxytryptamine-induced contractions of large coronary arteries of dog

  • Published:
Naunyn-Schmiedeberg's Archives of Pharmacology Aims and scope Submit manuscript

Summary

Large coronary arteries of the dog were contracted with 5-hydroxytryptamine (5-HT). The 5-HT2-receptor antagonist ketanserin antagonized the 5-HT-induced effects. Unlike Brazenor and Angus (Europ J Pharmacol 81: 569–576, 1982), who reported insurmountable antagonism of the effects of 5-HT in dog coronaries, we found that the antagonism by ketanserin can be surmounted, provided the concentrations of 5-HT are high enough. Ketanserin also unmasked a saturable component of the 5-HT-induced contractions. Although ketanserin (0.1–1 μmol/l) depressed the maximal force of the saturable component, it did not change its EC50 (-log mol/l 8.0). We conclude that large coronary arteries of dog are contracted by 5-HT mainly though 5-HT2-receptors and to a smaller extent through receptors different from 5-HT2.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Blinks JR (1965) Convenient apparatus, for recording contractions of isolated muscle. J Appl Physiol 20:755–757

    Google Scholar 

  • Brazenor RM, Angus JA (1981) Ergometrine contracts isolated canine coronary arteries by a serotonergic mechanism: No role for alpha adrenoceptors. J Pharmacol Exp Ther 218:530–536

    Google Scholar 

  • Brazenor RM, Angus JA (1982) Actions of serotonin antagonists on dog coronary artery. Eur J Pharmacol 81:569–576

    Google Scholar 

  • Fozard JR (1982) Mechanism of the hypotensive effect of ketanserin. J Cardiovasc Pharmacol 4:829–838

    Google Scholar 

  • Frenken M, Kaumann AJ (1984a) Interaction of ketanserin and its metabolite ketanserinol with 5-HT2-receptors in pulmonary and coronary arteries of calf. Naunyn-Schmiedeberg's Arch Pharmacol 326:334–339

    Google Scholar 

  • Frenken M, Kaumann AJ (1984b) Interconversion between two 5-HT2-receptor states in large coronary artery (CA) of calf. Proceedings of the 9th International Congress of Pharmacology, London, UK, p 170 P

  • Kaumann AJ (1983) Yohimbine and rauwolscine inhibit 5-hydroxytryptamine-induced contraction of large coronary arteries of calf through blockade of 5-HT2-receptors. Naunyn-Schmiedeberg's Arch Pharmacol 323:149–154

    Google Scholar 

  • Kaumann AJ, Frenken M (1984) A paradox: The 5-HT2-receptor antagonist ketanserin restores the 5-HT-induced contraction depressed by methysergide in large coronary arteries of calf Allosteric regulation of 5-HT2-receptors. Naunyn-Schmiedeberg's Arch Pharmacol 328:295–300

    Google Scholar 

  • Leysen JE, Niemegeers CJE, Van Nueten JM, Laduron PM (1982) [3H] Ketanserin (R 41468), a selective 3H-ligand for serotonin2 receptor binding sites. Binding properties, brain distribution and functional role. Mol Pharmacol 21:301–314

    Google Scholar 

  • Müller-Schweinitzer E, Engel G (1983) Evidence for mediation by 5-HT2 receptors of 5-hydroxytryptamine-induced contraction of canine basilar artery. Naunyn-Schmiedeberg's Arch Pharmacol 324:287–292

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Frenken, M., Kaumann, A.J. Ketanserin causes surmountable antagonism of 5-hydroxytryptamine-induced contractions of large coronary arteries of dog. Naunyn-Schmiedeberg's Arch. Pharmacol. 328, 301–303 (1985). https://doi.org/10.1007/BF00515557

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00515557

Key words

Navigation